The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment

Testing for treatment related biomarkers in clinical care, like Ras mutation status in colorectal cancer (CRC), has increased drastically over recent years. Reliable testing of these markers is pivotal for optimal treatment of patients. Participation in external quality assessment (EQA) programs is...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijkstra, Jeroen R., Tops, Bastiaan B. J., Nagtegaal, Iris D., van Krieken, J. Han J. M., Ligtenberg, Marjolijn J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552773/
https://www.ncbi.nlm.nih.gov/pubmed/26047774
http://dx.doi.org/10.1007/s00428-015-1789-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552773/
https://www.ncbi.nlm.nih.gov/pubmed/26047774
http://dx.doi.org/10.1007/s00428-015-1789-5

Ejemplares similares